Lv51
1140 积分 2024-09-01 加入
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases
2小时前
待确认
A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability
5天前
已完结
The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development
9天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
14天前
已完结
Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy
15天前
已完结
Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy
15天前
已完结
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
20天前
已完结
皖公网安备34019202002308
